P974: INTERIM ANALYSIS OF THE LAUNCH STUDY-A MULTICENTER, OPEN-LABEL STUDY OF SELINEXOR, DEXAMETHASONE PLUS CHEMOTHERAPY DRUGS IN RELAPSED/ REFRACTORY MULTIPLE MYELOMA

• Chunyan Sun,
• Baijun Fang,
• Guangxun Gao,
• Ai‑li He,
• Fei Zhao,
• Junying LI,
• Chun Zhang,
• Weiming LI,
• Hui Cheng,
• Huili Cai,
• Bin Chen,
• Jingming Guo,
• Yu Hu

Affiliations

Chunyan Sun

1 Union Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Department of hemotology, Wuhan, China

Baijun Fang

2 Henan Cancer Hospital, Department of hemotology, Zhengzhou, China

Guangxun Gao

3 Xijing hospital, Department of hemotology, Xi’an, China

Ai‑li He

4 Second Affiliated Hospital of Xi’an Jiaotong University, Department of hemotology, Xi’an, China

Fei Zhao

1 Union Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Department of hemotology, Wuhan, China

Junying LI

1 Union Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Department of hemotology, Wuhan, China

Chun Zhang

1 Union Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Department of hemotology, Wuhan, China

Weiming LI

1 Union Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Department of hemotology, Wuhan, China

Hui Cheng

5 Wuhan No.1 Hospital, Department of hemotology, Wuhan, China

Huili Cai

6 Center People’s Hospital of Yichang, Department of hemotology, Yichang, China

Bin Chen

7 Hubei Provincial Hospital of Traditional Chinese Medicine, Department of hemotology, Wuhan, China

Jingming Guo

6 Center People’s Hospital of Yichang, Department of hemotology, Yichang, China

Yu Hu

1 Union Hospital, Tongji Medical Collage, Huazhong University of Science and Technology, Department of hemotology, Wuhan, China